For patients with a genetic diagnosis of a hereditary cancer syndrome—such as Lynch syndrome, Li-Fraumeni syndrome, or familial adenomatous polyposis—early detection and proactive management are essential. The Mount Sinai High-Risk Cancer Surveillance Program provides comprehensive care, including personalized surveillance plans, access to advanced genetic screening, and coordination with a multidisciplinary team of specialists, including oncologists, genetic counselors, and gastroenterologists. By referring patients to our program, healthcare providers can ensure their patients receive cutting-edge care, participate in relevant clinical trials, and have access to educational resources tailored to their specific genetic risks.